VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venus Remedies Limited has submitted a quarterly compliance certificate for the period ended 30th June 2025, as required under SEBI's Prohibition of Insider Trading Regulations, 2015. The Compliance Officer, Neha, confirmed that the company maintains a Structured Digital Database (SDD) with proper access controls, audit trails, and non-tamperable records preserved for 8 years. One Unpublished Price Sensitive Information (UPSI) event was identified and captured during the quarter. No non-compliance was reported in the previous quarter, and no remedial actions were required.
This is a routine regulatory compliance filing and has no direct material impact on shareholders or the stock price. It simply confirms that the company is adhering to SEBI's insider trading disclosure norms, which is a positive sign of good governance practices.